Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 2056 AL 2070

Development and validation of the geriatric apathy scale: Examining multi-dimensional apathy profiles in a neurodegenerative population with cultural considerations

Yi HJ, Tan CH, Hong WP, Yu RL.

Asian J Psychiatr. 2024 Mar;93:103924. doi: 10.1016/j.ajp.2024.103924. Epub 2024 Jan 9.

Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?

de la Monte SM.

J Alzheimers Dis. 2024;101(s1):S317-S343. doi: 10.3233/JAD-240069.

Locus Coeruleus-Norepinephrine System: Spheres of Influence and Contribution to the Development of Neurodegenerative Diseases

Nikolenko VN, Borminskaya ID, Nikitina AT, Golyshkina MS, Rizaeva NA, Oganesyan MV.

Front Biosci (Landmark Ed). 2024 Mar 20;29(3):118. doi: 10.31083/j.fbl2903118.

Chiral nanomaterial-based approaches for diagnosis and treatment of protein-aggregated neurodiseases: current status and future opportunities

Pranav, Bajpai A, Dwivedi PK, Sivakumar S.

J Mater Chem B. 2024 Feb 21;12(8):1991-2005. doi: 10.1039/d3tb02381h.

Plasma lipidomic signatures of dementia with Lewy bodies revealed by machine learning, and compared to alzheimer's disease

Shen H, Yu Y, Wang J, Nie Y, Tang Y, Qu M.

Alzheimers Res Ther. 2024 Oct 15;16(1):226. doi: 10.1186/s13195-024-01585-7.

Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles

Liu X, Shen L, Wan M, Xie H, Wang Z.

J Nanobiotechnology. 2024 Apr 12;22(1):170. doi: 10.1186/s12951-024-02428-1.

Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease

Zhang T, Kim BM, Lee TH.

Transl Neurodegener. 2024 Jan 9;13(1):4. doi: 10.1186/s40035-023-00395-5.

The Role of Rab GTPases in the development of genetic and malignant diseases

Erol ÖD, Şenocak Ş, Aerts-Kaya F.

Mol Cell Biochem. 2024 Feb;479(2):255-281. doi: 10.1007/s11010-023-04727-x. Epub 2023 Apr 15.

Update on the role of T cells in cognitive impairment

Ruiz-Fernández I, Sánchez-Díaz R, Ortega-Sollero E, Martín P.

Br J Pharmacol. 2024 Mar;181(6):799-815. doi: 10.1111/bph.16214. Epub 2023 Sep 2.

Knowledge Structure and Emerging Trends of Mild Cognitive Impairment with Dyssomnias in Recent 20 Years: A Bibliometric Analysis via CiteSpace and VOSviewer

Huang H, Zhuang Z, Wan Y, Shi J, Yuan X, Wang D, Chen S.

Behav Neurol. 2024 Jan 6;2024:6622212. doi: 10.1155/2024/6622212. eCollection 2024.

Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer's Disease

Crook H, Edison P.

J Alzheimers Dis. 2024;101(s1):S357-S370. doi: 10.3233/JAD-240730.

Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure

Ogonowski NS, García-Marín LM, Fernando AS, Flores-Ocampo V, Rentería ME.

Transl Psychiatry. 2024 Apr 11;14(1):185. doi: 10.1038/s41398-024-02898-9.

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

Beghini DG, Kasai-Brunswick TH, Henriques-Pons A.

Int J Mol Sci. 2024 Feb 18;25(4):2392. doi: 10.3390/ijms25042392.

Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review

Kovalová M, Gottfriedová N, Mrázková E, Janout V, Janoutová J.

Otolaryngol Pol. 2024 Apr 9;78(2):1-17. doi: 10.5604/01.3001.0053.6158.

Cognitive Speed in Neurodegenerative Disease: Comparing Mean Rate and Inconsistency Within and Across the Alzheimer's and Lewy Body Spectra in the COMPASS-ND Study

Caballero HS, McFall GP, Gee M, MacDonald S, Phillips NA, Fogarty J, Montero-Odasso M, Camicioli R, Dixon RA.

J Alzheimers Dis. 2024;100(2):579-601. doi: 10.3233/JAD-240210.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias